m_and_a
confidence high
sentiment positive
materiality 0.85
Cross Country Healthcare to be acquired by Knox Lane for $13.25/share in $437M all-cash deal
CROSS COUNTRY HEALTHCARE INC
- Deal valued at ~$437M, with stockholders receiving $13.25 per share in cash.
- 31% premium to May 6 closing price and 45% premium to 90-day VWAP.
- Expected to close Q3 2026, subject to stockholder approval and HSR clearance.
- Company cancels Q1 2026 earnings call (May 7) and 2026 Annual Meeting (May 11).
- Equity financing from Knox Lane secured; termination fee of ~$14.2M applies.